Suzanne Angell

Director of Therapeutic Research at Casdin Capital

Suzanne Angell, Director of Therapeutic Research, joined Casdin Capital in 2012. Suzanne brings over 16 year of business and investment management experience across multiple platforms.

Prior to joining Casdin, Suzanne served as the Chief Operating Officer and Chief Financial Officer of Jungell, Inc., an organic food company. Previously, Suzanne served as a Managing Director and Advisor for Alpine ESD and C. Kenneth Imports, a real estate firm and food-importing company, respectively.

Suzanne began her career as a Research Analyst at Cooper Hill Partners, a healthcare-focused investment firm where she analyzed healthcare investments in life science tools, diagnostics and medical devices.

Suzanne earned a B.A. in English and Biology from Yale University and her Master of Arts in English Literature from Johns Hopkins University.

Links

Org chart

Timeline

  • Director of Therapeutic Research

    2020 - present

View in org chart